Trial Profile
A retrospective study to characterize brain metastases during vemurafenib treatment in melanoma patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Feb 2016
Price :
$35
*
At a glance
- Drugs Vemurafenib (Primary)
- Indications Malignant melanoma
- Focus Adverse reactions; Pharmacodynamics
- 09 Feb 2016 New trial record